It remains the biggest killer in Wales and has enormous ramifications for the NHS, crime, and even those who don't directly ...

Australia: A pooled analysis of the phase 3 BROOKLYN and BROADWAY trials showed that obicetrapib, when added to ...

Ultragenyx (RARE) stock is down 40% since March 2024 amid ongoing financial struggles. See more insights on its growth ...

Researchers have unveiled a new DNA-based therapy that silences the PCSK9 gene to lower cholesterol without statin side ...

Cardiovascular disease risk increases the longer US immigrants reside in the country, according to a recent study.

SYRACUSE, NY / ACCESS Newswire / October 16, 2025 / Repair Biotechnologies, Inc. ( a biotechnology company developing first-in-class therapies capable of rapidly reducing and stabilizing ...

High cholesterol levels can pose various health risks, including arteriosclerosis. Therefore, it's important to identify ...

CRISPR Therapeutics’ stock is surging as in-vivo therapies show promise. Learn about CRSP stock's risks, long-term upside, ...

Cholesterol takes a long time to get to dangerous levels in the body. If you test early, you can control it with lifestyle ...

Statins are considered safe and effective, but they may not be right for everyone to lower cholesterol.

This finding contradicts some recent studies indicating the number of people with cardiovascular disease who did not have any ...